4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-016793
CEO and CFO bought 12,000 shares at $7.91 ($94,920)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-14 | Purchase | +12,000 | $7.91 | $94,920 | 2,675,886 | D |
| Open-market purchases · 12,000 sh · avg $7.91 · $94,920 | |||||||
Loading xslF345X03/ownership.xml…